本文選題：噻嗪 + 高血壓人群��； 參考：《中華高血壓雜志》2017年04期

【摘要】：正冉擘力(重慶市人民醫(yī)院心內(nèi)科,重慶400014)大量循證醫(yī)學(xué)證據(jù)顯示,高血壓人群收縮壓每降低2mmHg(1mmHg=0.133kPa),缺血性心臟病死亡率將降低7%、腦卒中死亡率降低10%。從這個意義來看,降壓達(dá)標(biāo)是硬道理�，F(xiàn)有各項大型臨床研究結(jié)果顯示,血壓達(dá)標(biāo)至少需要聯(lián)合用藥≥2種,而影響中國患者降壓依從性的最主要因素包括患者年齡和應(yīng)用藥物的種類。年齡≥65
[Abstract]:A large number of evidence-based medical evidence showed that for every decrease in systolic blood pressure of 2 mm Hg-1 mmHg 0.133 KPA, the mortality of ischemic heart disease would be reduced by 7%, and the mortality rate of stroke would decrease by 10% in Zhengzhan (Cardiology Department of Chongqing people's Hospital, Chongqing 400014). From this point of view, lowering the standard of blood pressure is the last word. The results of various large clinical studies show that at least two kinds of combined drugs are needed to meet the blood pressure standard, and the most important factors affecting Chinese patients' hypotensive compliance include the age of patients and the kinds of drugs used. Age 鈮，

本文編號：1957628